• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cosmos Health Inc. - Common Stock (NQ:COSM)

0.3313 -0.0051 (-1.52%)
Delayed Quote Updated: 4:00 PM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cosmos Health Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
News headline image
Cosmos Health Reaches 6,287 Active U.S. Subscriptions, Substantially All Added Since Mid-September, with 60.5% of Online Checkout Orders Including a Subscription
October 14, 2026
● 6,287 active U.S. subscriptions as of October 14, 2026, the vast majority added since mid-September as the Company accelerates investment in its U.S. platform ● 60.5% of U.S. online checkout orders... 
From Cosmos Health Inc.
Via ACCESS Newswire
News headline image
Cosmos Health Reports Record Single-Day Direct-to-Consumer Sales in the United States Above $92,000, with $902,000 in Sales Over the Past 30 Days
October 13, 2026
Record day: U.S. direct-to-consumer sales exceeded $92,000 on October 11, 2026, the highest single day to date $902,000 in 30 days: approximately $30,000 in average daily sales over the trailing 30-day... 
From Cosmos Health Inc.
Via ACCESS Newswire
News headline image
Cosmos Health Reports Record Preliminary Nine-Month Revenue of $54.3 Million, Up 19% Year Over Year; Delivers Record Q3 Revenue of $17.4 Million and Reaffirms 2026 Revenue Outlook of Over $90 Million
October 07, 2026
Record nine-month revenue of approximately $54.3 million - up 19%, or $8.7 million, from $45.6 million in the same period of 2025 Nine-month 2026 revenue nearly matches the whole of 2024 - when... 
From Cosmos Health Inc.
Via ACCESS Newswire
News headline image
Cosmos Health's Brands Reach More Than 40 Countries Across Europe, the Middle East, North America and Asia, Addressing Global Markets Estimated at Approximately $946 Billion
October 01, 2026
More than 15 proprietary brands and product lines, plus 10 branded generics - across nutraceuticals, infection control, advanced formulations, skin care and mother & baby, and branded generics... 
From Cosmos Health Inc.
Via ACCESS Newswire
News headline image
Cosmos Health's CosmoFarm Reaches Record Annualized Revenue Above $60 Million, Up 4.3x Under Cosmos Health Ownership, as Robotics and AI Build Capacity to Support Over $100 Million in Annualized Revenue
September 29, 2026
Record Q2 2026 revenue of over $15 million , an annualized run-rate of over $60 million, at wholly owned subsidiary CosmoFarm Revenue up 4.3x under Cosmos Health ownership - from ~$14 million in fiscal... 
From Cosmos Health Inc.
Via ACCESS Newswire
News headline image
Cosmos Health's Contract Manufacturing Division Surpasses $20 Million in Implied Revenue and $18 Million in Implied Gross Profit Across Its Record 32.7 Million-Unit Production Pipeline
September 28, 2026
Contract manufacturing pipeline surpasses $20 million in implied revenue at wholly owned subsidiary Cana Laboratories, representing over $18 million in implied gross profit across the life of... 
From Cosmos Health Inc.
Via ACCESS Newswire
News headline image
Cosmos Health Adds 5.2 Million Units in New Five-Year Agreements with Target Pharma; Orderbook Surges Past 32.7 Million Units, Up 31% Since June
September 15, 2026
7.7 million contracted units added in under two weeks - Cana Laboratories' orderbook has grown from over 12 million units earlier this year to more than 32.7 million today Secured orders for 1.04... 
From Cosmos Health Inc.
Via ACCESS Newswire
News headline image
Cosmos Health Moves to Tokenize CCX0722 Intellectual Property in Innovative Non-Dilutive Structure, Eyes $562 Billion Weight-Management Market
September 14, 2026
Prime Ledger engaged to structure an asset-specific, non-dilutive tokenized financing for CCX0722 - backed by intellectual property, with no issuance of Cosmos Health common stock Positions Cosmos... 
From Cosmos Health Inc.
Via ACCESS Newswire
News headline image
Cosmos Health Secures Additional 2.5 Million Units Under New Five-Year Contract Manufacturing Agreement with Viofar; Total Orderbook Surpasses 27.5 Million Units
September 11, 2026
500,000 contracted units of ROSARTIA annually / 2.5 million over five years through a new long-term agreement at wholly owned subsidiary Cana Laboratories Expands Cosmos Health's manufacturing presence... 
From Cosmos Health Inc.
Via ACCESS Newswire
News headline image
Cosmos Health Launches C-ScrubVet in the UK, Advancing into the $69 Billion Global Animal Health Market
September 09, 2026
First orders received for the Company's veterinary antimicrobial line, which will be marketed under the brand name C-ScrubVet Formulated for dogs, cats, horses, companion and large animals , and... 
From Cosmos Health Inc.
Via ACCESS Newswire
News headline image
Cosmos Health: A Company Transformed — 2026 Year-to-Date
September 03, 2026
Record Revenue Across All Quarters Reported. Balance Sheet Deleveraged. Capital Structure Streamlined. Proprietary IP Filed in Four Global Markets. U.S. Market Entered. Global rollout of proprietary... 
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Strengthens Balance Sheet and Streamlines Capital Structure; Retires $8M ATW Convertible Note One Year Ahead of Maturity, Eliminating Further Dilution From Conversions
August 28, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Projects Over $6M in Annual Revenue and $4.3M in Gross Profit from Oliv18™ Across the U.S. Cardiovascular Health and Antioxidant Categories
August 24, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Enters Saudi Arabia Through Exclusive Distribution Agreement With Innova Healthcare; Secures Initial Purchase Order of 126,000 Sky Premium Life Units, With More Than 5 Million Units Expected Over Initial 5-Year Term
August 20, 2026
Innova is backed by leading investors and healthcare groups: Alkhabeer Capital, with more than $2.5 billion AUM; Tamer Group, a pharma manufacturing partner to Astellas and Daiichi Sankyo; and Cigalah... 
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Reports Q2 2026 Results: Record Q2 and H1 Revenue of $19.0M and $36.9M, Up 29% and 30%; Q2 Adjusted Gross Profit Up 58%; Total Liabilities Reduced 13%; Stockholders' Equity Up 12%; $5M Share Repurchase Program Underway
August 19, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Advances Its Technology-Driven Transformation with an AI-Enabled Subscription Platform Across B2C and B2B Channels
July 27, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Expands Pharma Cell Partnership in Albania with Annualized Orders Projected to Exceed 54,000 Units
July 20, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Share Buyback Expands to 5.11 Million Shares; Continues Open Market Repurchases
July 17, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Share Buyback Surpasses $1 Million, Reaching 4.84 Million Shares; Continues Open Market Repurchases
July 16, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Share Buyback Surpasses 4.5 Million Shares; Continues Open Market Repurchases
July 15, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Share Buyback Expands to 4.49 Million Shares; Continues Open Market Repurchases
July 14, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Share Buyback Reaches 4.36 Million Shares; Continues Open Market Repurchases
July 13, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Accelerates Prescription Medicine Strategy with Libytec Partnership to Commercialize DIABIT-IS X in Greece
July 13, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Launches Subscription Model
July 10, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Expands Share Buyback to 4.14 Million Shares; Continues Open Market Repurchases
July 09, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Share Buyback Surpasses 4 Million Shares; Continues Open Market Repurchases
July 08, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Share Buyback Expands to 3.87 Million Shares; Continues Open Market Repurchases
July 07, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Reports Preliminary Record Q2 and H1 2026 Revenue, Up Over 30% Year-Over-Year; Continues Open Market Share Repurchases
July 07, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Share Buyback Increases to 3.64 Million Shares; Continues Open Market Purchases
July 06, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Expands Buyback to 3.42 Million Shares With Additional 770,000-Share Repurchase; Continues Open Market Purchases
July 02, 2026
From Cosmos Health Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap